30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Lennart Hansson

Insider profile

Performance

Overall performance
1.5

Performance over holding periods
1.5
30 days 90 days 120 days
Average return -16% 8.2% 15.1%
Success rate 16% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Lennart Hansson's trades of Cinclus Pharma Holding publ AB's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-06-20 2024-06-20 B Purchase
56,670
396.53
SEK3,788,092
56,670 396.53 SEK3,788,092
2024-06-20 2024-06-20 B Purchase
61,596
110.83
SEK850,050
61,596 110.83 SEK850,050
2024-06-20 2024-06-20 B Purchase
38,688
179.84
SEK35,356
38,688 179.84 SEK35,356
2023-12-22 2023-12-21
SE Medivir AB (MVIR-B)
B Purchase
20,000
2.65
SEK53,000
20,000 2.65 SEK53,000
2021-02-05 2021-02-05 B Purchase
360,000
1.20
SEK432,000
360,000 1.20 SEK432,000
2020-02-17 2020-02-17 B Purchase
3,000
112.00
SEK336,000
3,000 112.00 SEK336,000
2019-09-20 2019-09-20 B Purchase
42,000
7.20
SEK302,600
42,000 7.20 SEK302,600
2018-11-06 2018-11-05 B Purchase
9,000
44.00
SEK396,000
9,000 44.00 SEK396,000
2018-11-05 2018-11-05 B Purchase
9,000
44.00
SEK396,000
9,000 44.00 SEK396,000
2018-05-18 2018-05-17 B Purchase
30,000
6.19
SEK185,658
30,000 6.19 SEK185,658